Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250223 · ClinicalTrials.gov registry record
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
A clinical trial, sponsored by Associazione Angela Serra per la ricerca sul cancro.
- Completed
- Registry status
- 1,093
- Enrollment target
NCT01250223: Completed study, sponsored by Associazione Angela Serra per la ricerca sul cancro.
NCT01250223 is a clinical trial that has completed, run by Associazione Angela Serra per la ricerca sul cancro. The registered enrollment target is 1,093 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01250223 has completed, sponsored by Associazione Angela Serra per la ricerca sul cancro.
- COMPLETED
- Registry status
- 1,093 participants
- Enrollment target
Study Summary
The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International Prognostic Index (FLIPI). The F2-study is designed as a prospective collection of information potentially useful to predict the prognosis of newly diagnosed Follicular Lymphoma patients, and its purposes are to validate the FLIPI and to verify whether a prognostic collection of data would allow the development of a more accurate prognostic index.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,093 participants |
| Start Date | 2003-02 |
| Est. Completion | 2016-12 |
What the finished NCT01250223 record still lists
NCT01250223 is an observational study that tracks outcomes without assigning an intervention. Its 1,093 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01250223 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01250223 about?
NCT01250223 is a clinical study titled "Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)". The F2-study is a complement of the previous studies of the Follicular Lymphoma Prognostic Factors Project which permitted the development of the Follicular Lymphoma International Prognostic Index (FLIPI). The F2-study is designed as a prospective collection of information potentially useful to pre...
What is the current status of trial NCT01250223?
This trial is currently completed. The enrollment target is 1,093 participants. The study started on 2003-02. Estimated completion is 2016-12.
Who is sponsoring clinical trial NCT01250223?
This trial is sponsored by Associazione Angela Serra per la ricerca sul cancro, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03754114 · 1,094 participants · NA
Brain Oxygen Optimization in Severe TBI, Phase 3
- NCT06118983 · 1,094 participants · NA
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
- NCT06585241 · 1,094 participants · Phase 4
A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
- NCT07196722 · 1,092 participants · Phase 2
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia